Baker Cyst
Title: Baker Cyst
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 1/18/2008
NicOx Completes Enrollment In Second Pivotal Phase 3 Study For Naproxcinod And Provides Development Update
NicOx S.A. (Eurolist: COX) announced it has successfully completed the enrollment of 1020 patients in the 302 pivotal phase 3 study for naproxcinod, in-line with projections. Naproxcinod is the Company’s lead investigational drug product and the first compound in the COX-Inhibiting Nitric Oxide-Donating (CINOD) class.
New Study Uncovers Prevalence, Burden Of Pediatric Arthritis In U.S.
A study published in the December issue of Arthritis Care & Research estimates that 294,000 U.S. children and teenagers under age 18 (or one in 250 children) have been diagnosed with arthritis or another rheumatologic condition. The study, conducted by the Centers for Disease Control and Prevention (CDC), provides for the first time a more accurate estimate of the number of children diagnosed with arthritis and related conditions across the U.S.
